These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20416097)

  • 1. Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Apr; 9():18. PubMed ID: 20416097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Jun; 9():28. PubMed ID: 20573265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Jan; 9():6. PubMed ID: 20148109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Apr; 9():17. PubMed ID: 20416096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Mar; 9():11. PubMed ID: 20205742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2009 Dec; 8():26. PubMed ID: 20025739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report.
    Kishimoto A; Todani A; Miura J; Kitagaki T; Hashimoto K
    Ann Gen Psychiatry; 2010 May; 9():23. PubMed ID: 20492642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multi-Center Thai University-Based Surgical Intensive Care Units Study (THAI-SICU Study): Outcome of ICU Care and Adverse Events.
    Kongsayreepong S; Chittawatanarat K; Thawitsri T; Chatmongkolchart S; Morakul S; Wacharasint P; Chau-In W; Poopipatpab S; Kusumaphanyo C
    J Med Assoc Thai; 2016 Sep; 99 Suppl 6():S1-S14. PubMed ID: 29906064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine.
    Albayrak Y; Beyazyüz M; Abbak Ö; Altındağ E
    Clin Psychopharmacol Neurosci; 2019 Feb; 17(1):134-138. PubMed ID: 30690950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of delirium in the pediatric intensive care unit.
    Turkel S; Hanft A; Epstein D; Jacobson J
    J Pediatr Intensive Care; 2013 Dec; 2(4):169-176. PubMed ID: 31214439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between sedation, delirium and post-traumatic stress disorder and their impact on quality of life and memories following discharge from an intensive care unit.
    Svenningsen H
    Dan Med J; 2013 Apr; 60(4):B4630. PubMed ID: 23651729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic Drug Use and Screening for Delirium in Mechanically Ventilated Patients in Canadian Intensive Care Units: An Observational Study.
    Thiboutot Z; Perreault MM; Williamson DR; Rose L; Mehta S; Guenette MD; Cook D; Burry L
    Can J Hosp Pharm; 2016; 69(2):107-13. PubMed ID: 27168631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I-SAVE study: impact of sedation, analgesia, and delirium protocols evaluated in the intensive care unit: an economic evaluation.
    Awissi DK; Bégin C; Moisan J; Lachaine J; Skrobik Y
    Ann Pharmacother; 2012 Jan; 46(1):21-8. PubMed ID: 22202496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?
    Hashimoto K
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):470-4. PubMed ID: 19702566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delirium in patients admitted to a cardiac intensive care unit with cardiac emergencies in a developing country: incidence, prevalence, risk factor and outcome.
    Lahariya S; Grover S; Bagga S; Sharma A
    Gen Hosp Psychiatry; 2014; 36(2):156-64. PubMed ID: 24295565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Evaluation of Adverse Drug Reactions Associated With Antipsychotic Use for the Treatment of Delirium in the Intensive Care Unit.
    Hale GM; Kane-Gill SL; Groetzinger L; Smithburger PL
    J Pharm Pract; 2016 Aug; 29(4):355-60. PubMed ID: 25609664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter assessment of sedation and delirium practices in the intensive care units in Poland - is this common practice in Eastern Europe?
    Kotfis K; Zegan-Barańska M; Żukowski M; Kusza K; Kaczmarczyk M; Ely EW
    BMC Anesthesiol; 2017 Sep; 17(1):120. PubMed ID: 28865447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgosedation of adult patients with elevated intracranial pressure : Survey of current clinical practice in Austria.
    Herzer G; Mirth C; Illievich UM; Voelckel WG; Trimmel H
    Wien Klin Wochenschr; 2018 Jan; 130(1-2):45-53. PubMed ID: 28733841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of doctors' and nurses' perceptions and implementation of delirium management in intensive care unit].
    Luo HB; Wang XT; Tang B; Zhu ZN; Guo HL; Li ZZ; Sun JH; Liu DW
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):930-934. PubMed ID: 29202534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.